# Atea Pharmaceuticals, Inc.: Form DEF 14A, filed Apr 26, 2024

- Company: [Atea Pharmaceuticals, Inc.](/companies/avir.md) (CIK 1593899)
- Form: DEF 14A
- Filed: 2024-04-26
- Accepted by EDGAR: Apr 26, 2024, 20:21 ET
- Period: 2024-06-21
- Accession: 0000950170-24-049178
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1593899/000095017024049178/avir-20240426.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1593899/000095017024049178/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1593899/000095017024049178/avir-20240426.htm

Filed Apr 26, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-049178. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.